PHAR
Pharming GroupANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
PHAR vs peer average
81/100
PHAR vs. peer average (A vs. C)
Grade spread
A 2 · B 3 · C 2 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CTMX is the first available peer comparator.
Small-cap biotech risk comparator with pipeline optionality, but oncology focus makes it a loose peer and mainly useful for binary development-risk framing.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PHAR
Pharming Group
CTMX
CytomX Therapeutics
Grade
A
C
Momentum
65
8
Value
62
53
Sentiment
63
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CTMX
PHAR / CTMX
Grade Position
Above peers
PHAR vs. peer average (A vs. C)
81/100
Momentum
65
PHARValue
62
PHARSentiment
63
CTMXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PHAR
CTMX is the first peer returned for this comparison set.